Complete Filing Data
GENELUX Corp reported Stockholders Equity of $11.54 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GENELUX Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | -$32.1M | -$29.9M | -$28.3M | -$5.2M |
| Research And Development Expense | $19.9M | $19.0M | $12.8M | $9.1M |
| Operating Income Loss | -$33.2M | -$31.7M | -$24.2M | -$3.0M |
| Operating Expenses | $33.2M | $31.7M | $24.3M | $14.1M |
| Nonoperating Income Expense | $1.1M | $1.8M | -$4.1M | -$1.1M |
| General And Administrative Expense | $13.4M | $12.7M | $11.6M | $5.0M |
| Comprehensive Income Net Of Tax | -$32.2M | -$29.8M | -$28.3M | -$5.2M |
| Revenue From Contract With Customer Excluding Assessed Tax | $8.0K | $8.0K | $170.0K | $11.1M |
| Adjustments To Additional Paid In Capital Cost Of Stock Option Modifications And Repricing | $806.0K | $332.0K | $2.7M | |
| Cost Of Stock Option Modifications Repricing | -$806.0K | -$332.0K | -$2.7M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$55.0K | $50.0K | ||
| Interest Expense Debt Excluding Amortization | $173.0K | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$8.0M | -$7.5M | -$7.5M | -$6.5M | -$6.6M | -$7.9M | -$5.3M | -$5.8M | -$10.4M | $4.9M | -$2.8M | -$3.8M |
| Research And Development Expense | $4.7M | $4.8M | $4.7M | $4.1M | $4.4M | $4.0M | $2.8M | $2.9M | $2.8M | $2.4M | $1.8M | $2.4M |
| Operating Income Loss | -$8.2M | -$7.8M | -$7.8M | -$6.9M | -$6.9M | -$8.1M | -$5.3M | -$5.4M | -$6.5M | $6.3M | -$2.8M | -$3.5M |
| Operating Expenses | $8.2M | $7.8M | $7.8M | $6.9M | $6.9M | $8.1M | $5.3M | $5.4M | $6.6M | $4.7M | $2.8M | $3.5M |
| Nonoperating Income Expense | $244.0K | $336.0K | $324.0K | $474.0K | $316.0K | $265.0K | -$38.0K | -$426.0K | -$3.9M | -$335.0K | -$21.0K | -$337.0K |
| General And Administrative Expense | $3.5M | $3.0M | $3.1M | $2.9M | $2.5M | $4.1M | $2.5M | $2.5M | $3.8M | $2.2M | $972.0K | $1.1M |
| Comprehensive Income Net Of Tax | -$7.9M | -$7.5M | -$7.5M | -$6.3M | -$6.6M | -$7.9M | -$5.3M | -$5.8M | -$10.4M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $8.0K | $170.0K | $11.0M | |||||||||
| Adjustments To Additional Paid In Capital Cost Of Stock Option Modifications And Repricing | $724.0K | $7.0K | $6.0K | $6.0K | $6.0K | $314.0K | $25.0K | |||||
| Cost Of Stock Option Modifications Repricing | -$6.0K | -$314.0K | -$2.6M | |||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $5.0K | -$26.0K | -$35.0K | $135.0K | -$6.0K | -$19.0K | ||||||
| Interest Expense Debt Excluding Amortization | $24.0K | $143.0K | $286.0K | $285.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $11.5M | $26.3M | $19.5M | -$35.8M | -$33.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.3M | $8.6M | $9.4M | $397.0K | $4.5M |
| Operating Lease Right Of Use Asset | $1.6M | $1.8M | $2.4M | $1.3M | |
| Treasury Stock Value | $433.0K | $433.0K | $433.0K | $433.0K | |
| Treasury Stock Common Shares | 433.3K | 433.3K | 433.3K | 433.3K | |
| Retained Earnings Accumulated Deficit | -$283.5M | -$251.4M | -$221.5M | -$189.8M | |
| Property Plant And Equipment Net | $2.2M | $1.3M | $1.2M | $644.0K | |
| Prepaid Expense And Other Assets Current | $535.0K | $653.0K | $1.0M | $1.5M | |
| Other Assets Noncurrent | $144.0K | $92.0K | $92.0K | $92.0K | |
| Operating Lease Liability Noncurrent | $1.3M | $1.5M | $1.9M | $1.2M | |
| Operating Lease Liability Current | $427.0K | $329.0K | $653.0K | $266.0K | |
| Liabilities Current | $6.2M | $6.9M | $6.6M | $31.6M | |
| Liabilities And Stockholders Equity | $19.0M | $34.7M | $27.9M | $5.5M | |
| Liabilities | $7.5M | $8.4M | $8.4M | $41.3M | |
| Common Stock Value | $38.0K | $35.0K | $27.0K | $9.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.2M | -$853.0K | $9.0M | -$4.1M | |
| Assets Current | $15.1M | $31.5M | $24.2M | $1.9M | |
| Assets | $19.0M | $34.7M | $27.9M | $5.5M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $9.0K | $64.0K | $14.0K | $2.0K | |
| Accounts Payable And Accrued Liabilities Current | $4.4M | $5.6M | $3.8M | $6.8M | |
| Cash And Cash Equivalents At Carrying Value | $5.3M | $8.6M | $9.4M | $397.0K | |
| Assets Noncurrent | $3.7M | $3.6M | |||
| Unrealized Gain Loss On Investments | -$55.0K | $50.0K | $12.0K | ||
| Accrued Payroll Taxes Current | $1.4M | $1.0M | $2.1M | $2.9M | |
| Short Term Investments | $13.8M | ||||
| Amortization Of Debt Discount Premium | $649.0K | $258.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $757.0K | $62.0K | |||
| Payment Of Deferred Offering Costs | $303.0K | $1.6M | |||
| Extension Of Rightofuse Asset And Operating Lease | $1.6M | $686.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $18.6M | $23.9M | $29.8M | $33.1M | $37.7M | $15.1M | $24.0M | $22.3M | $2.7M | -$32.3M | -$39.1M | -$36.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.7M | $6.5M | $16.2M | $6.1M | $7.9M | $4.1M | $29.9M | $27.1M | $10.3M | $1.4M | $4.2M | $7.2M | |||
| Operating Lease Right Of Use Asset | $1.5M | $1.6M | $1.7M | $1.9M | $2.1M | $2.3M | $1.8M | $1.7M | $1.9M | $1.3M | $656.0K | $439.0K | |||
| Treasury Stock Value | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | ||||||
| Treasury Stock Common Shares | 433.3K | 433.3K | 433.3K | 433.3K | 433.3K | 433.3K | 433.3K | 433.3K | 433.3K | ||||||
| Retained Earnings Accumulated Deficit | -$274.3M | -$266.3M | -$258.9M | -$242.4M | -$236.0M | -$229.4M | -$214.8M | -$209.4M | -$203.6M | ||||||
| Property Plant And Equipment Net | $1.8M | $1.3M | $1.3M | $1.3M | $1.3M | $1.1M | $1.0M | $878.0K | $617.0K | ||||||
| Prepaid Expense And Other Assets Current | $637.0K | $1.3M | $843.0K | $1.9M | $1.2M | $1.6M | $1.3M | $1.5M | $1.7M | ||||||
| Other Assets Noncurrent | $123.0K | $73.0K | $73.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | ||||||
| Operating Lease Liability Noncurrent | $1.3M | $1.4M | $1.5M | $1.6M | $1.7M | $1.8M | $1.3M | $1.2M | $1.4M | ||||||
| Operating Lease Liability Current | $354.0K | $345.0K | $337.0K | $415.0K | $500.0K | $584.0K | $567.0K | $585.0K | $568.0K | ||||||
| Liabilities Current | $5.1M | $7.0M | $7.7M | $5.6M | $5.8M | $7.8M | $8.8M | $7.9M | $10.5M | ||||||
| Liabilities And Stockholders Equity | $25.0M | $32.2M | $39.0M | $40.3M | $45.2M | $24.7M | $34.1M | $31.4M | $14.6M | ||||||
| Liabilities | $6.4M | $8.3M | $9.1M | $7.2M | $7.5M | $9.6M | $10.0M | $9.1M | $11.9M | ||||||
| Common Stock Value | $38.0K | $38.0K | $38.0K | $35.0K | $35.0K | $27.0K | $27.0K | $26.0K | $25.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $7.6M | -$5.4M | $9.9M | $2.7M | |||||||||||
| Assets Current | $21.6M | $29.2M | $35.9M | $36.0M | $34.9M | $21.2M | $31.2M | $28.7M | $12.1M | ||||||
| Assets | $25.0M | $32.2M | $39.0M | $40.3M | $45.2M | $24.7M | $34.1M | $31.4M | $14.6M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $8.0K | $3.0K | $29.0K | $124.0K | -$11.0K | -$5.0K | $2.0K | $2.0K | $2.0K | ||||||
| Accounts Payable And Accrued Liabilities Current | $4.0M | $6.0M | $6.7M | $4.5M | $4.8M | $5.3M | $4.0M | $4.5M | $5.3M | ||||||
| Cash And Cash Equivalents At Carrying Value | $6.5M | $16.2M | $6.1M | $7.9M | $4.1M | $29.9M | $27.1M | $10.3M | |||||||
| Assets Noncurrent | $3.4M | $3.0M | $3.0M | $3.2M | $4.3M | $10.3M | $3.5M | $2.9M | $2.7M | $2.6M | |||||
| Unrealized Gain Loss On Investments | $5.0K | -$26.0K | -$35.0K | $135.0K | -$6.0K | -$19.0K | |||||||||
| Accrued Payroll Taxes Current | $785.0K | $610.0K | $664.0K | $686.0K | $517.0K | $1.9M | $4.1M | ||||||||
| Short Term Investments | $16.2M | $21.4M | $18.9M | $22.3M | $28.0M | $25.8M | $15.6M | ||||||||
| Amortization Of Debt Discount Premium | $649.0K | $49.0K | $50.0K | $49.0K | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $140.0K | $151.0K | |||||||||||||
| Payment Of Deferred Offering Costs | $303.0K | ||||||||||||||
| Extension Of Rightofuse Asset And Operating Lease | $649.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Increase Decrease In Operating Lease Liability | -$337.0K | -$651.0K | -$523.0K | -$389.0K |
| Net Cash Provided By Used In Operating Activities | -$25.3M | -$21.2M | -$20.3M | -$3.6M |
| Share Based Compensation | $5.9M | $5.7M | $2.5M | $2.4M |
| Payments To Acquire Property Plant And Equipment | $1.1M | $381.0K | $1.0M | $49.0K |
| Net Cash Provided By Used In Investing Activities | $12.1M | -$8.1M | -$14.7M | -$49.0K |
| Net Cash Provided By Used In Financing Activities | $9.9M | $28.5M | $44.0M | -$478.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$66.0K | -$359.0K | -$483.0K | $168.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.2M | $2.2M | -$2.4M | $2.3M |
| Proceeds From Issuance Of Warrants | $224.0K | $688.0K | $3.0M | $120.0K |
| Proceeds From Issuance Of Common Stock | $9.6M | $27.7M | $25.1M | |
| Payments To Acquire Investments | $18.3M | $29.0M | $13.7M | |
| Increase Decrease In Accrued Taxes Payable | $438.0K | -$1.1M | -$735.0K | |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $31.5M | $21.3M | ||
| Increase Decrease In Interest Payable Net | $22.0K | $886.0K | ||
| Increase Decrease In Deferred Revenue | -$170.0K | -$4.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|
| Increase Decrease In Operating Lease Liability | -$81.0K | -$148.0K | -$114.0K | $686.0K | -$80.0K |
| Net Cash Provided By Used In Operating Activities | -$5.4M | -$4.4M | -$4.6M | $2.8M | |
| Share Based Compensation | $1.4M | $1.5M | $227.0K | $372.0K | |
| Payments To Acquire Property Plant And Equipment | $30.0K | $30.0K | $109.0K | $15.0K | |
| Net Cash Provided By Used In Investing Activities | $3.5M | -$1.7M | -$109.0K | -$15.0K | |
| Net Cash Provided By Used In Financing Activities | $9.6M | $688.0K | $14.6M | -$130.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $171.0K | $565.0K | $223.0K | -$377.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.1M | $1.5M | -$913.0K | $7.0K | |
| Proceeds From Issuance Of Warrants | $688.0K | ||||
| Proceeds From Issuance Of Common Stock | $9.6M | $14.5M | |||
| Payments To Acquire Investments | $2.5M | $3.2M | |||
| Increase Decrease In Accrued Taxes Payable | -$340.0K | -$209.0K | |||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $6.0M | $1.5M | |||
| Increase Decrease In Interest Payable Net | $92.0K | $142.0K | |||
| Increase Decrease In Deferred Revenue | -$170.0K | $5.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 37.2M | 31.5M | 31.5M | 9.1M |
| Earnings Per Share Basic | $-0.86 | $-0.95 | $-1.16 | $-0.57 |
| Weighted Average Number Of Diluted Shares Outstanding | 37.2M | 31.5M | 24.4M | 9.1M |
| Earnings Per Share Diluted | $-0.86 | $-0.95 | $-1.16 | $-0.57 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 75.0M |
| Common Stock Shares Outstanding | 38.1M | 34.7M | 26.8M | 9.1M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 38.1M | 34.7M | 26.8M | 9.1M |
| Preferred Stock Shares Authorized | 10.0M | 29.9M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $22,095.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 22.1M | ||
| Preferred Stock Shares Issued | 0.00 | 22.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 37.9M | 37.9M | 34.9M | 34.5M | 29.7M | 26.8M | 26.2M | 25.1M | 19.6M | 9.1M | 9.1M | 9.1M | |
| Earnings Per Share Basic | $-0.21 | $-0.20 | $-0.21 | $-0.19 | $-0.22 | $-0.29 | $-0.20 | $-0.23 | $-0.53 | $0.54 | $0.31 | $-0.42 | |
| Weighted Average Number Of Diluted Shares Outstanding | 37.9M | 37.9M | 34.9M | 34.5M | 29.7M | 26.8M | 26.2M | 25.1M | 19.6M | 10.1M | 9.1M | ||
| Earnings Per Share Diluted | $-0.21 | $-0.20 | $-0.21 | $-0.19 | $-0.22 | $-0.29 | $-0.20 | $-0.23 | $-0.53 | $0.49 | $0.31 | ||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||
| Common Stock Shares Outstanding | 38.0M | 37.8M | 37.7M | 34.5M | 34.5M | 27.0M | 26.7M | 25.9M | 24.6M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 37.8M | 37.7M | 34.5M | 34.5M | 27.0M | 26.7M | 25.9M | 24.6M | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 29.9M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.7M | $2.5M | $2.4M | |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $898.0K | $2.0M | $940.0K | |
| Depreciation | $244.0K | $235.0K | $499.0K | $553.0K |
| Rightofuse Asset | $330.0K | $668.0K | $519.0K | $415.0K |
| Investment Income Interest | $711.0K | $700.0K | $182.0K | |
| Additional Paid In Capital | $295.5M | $278.0M | $241.4M | $154.4M |
| Fair Value Of Restricted Stock Units | $898.0K | $2.0M | $940.0K | |
| Stock Issued During Period Value Other | $224.0K | $688.0K | $3.0M | $120.0K |
| Stock Issued During Period Value New Issues | $25.1M | |||
| Bond Accretion Income | $358.0K | $757.0K | $62.0K | |
| Stock Issued During Period Value Stock Options Exercised | $14.0K | $1.5M | ||
| Interest Paid Net | $72.0K | $264.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $1.4M | $1.5M | $1.3M | $1.5M | $515.0K | $240.0K | $227.0K | $1.7M | $297.0K | $372.0K | |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $291.0K | $185.0K | $103.0K | $227.0K | $136.0K | $989.0K | $147.0K | $429.0K | $198.0K | |||
| Depreciation | $61.0K | $59.0K | $56.0K | $84.0K | $136.0K | $138.0K | ||||||
| Rightofuse Asset | $80.0K | $164.0K | $118.0K | $102.0K | ||||||||
| Investment Income Interest | $175.0K | $224.0K | $184.0K | $222.0K | $163.0K | $114.0K | $4.0K | |||||
| Additional Paid In Capital | $293.3M | $290.6M | $289.1M | $275.8M | $274.0M | $244.9M | $239.2M | $232.1M | $206.7M | |||
| Fair Value Of Restricted Stock Units | $103.0K | $989.0K | $198.0K | |||||||||
| Stock Issued During Period Value Other | $27.7M | $688.0K | $1.6M | $1.2M | $120.0K | |||||||
| Stock Issued During Period Value New Issues | $9.6M | $3.5M | $21.6M | $12.6M | ||||||||
| Bond Accretion Income | $69.0K | $112.0K | $140.0K | $252.0K | $153.0K | $151.0K | ||||||
| Stock Issued During Period Value Stock Options Exercised | $14.0K | $688.0K | $1.3M | $1.2M | ||||||||
| Interest Paid Net | $50.0K | $146.0K |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.